SCHEMBL8461963

SCHEMBL8461963

CC(C)(C)c1cc(NCc2ccc(C(=O)O)cc2)cc(C(C)(C)C)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 5/20 0.60
EPHX2 P34913 4/20 0.60
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
RXRA P19793 3/20 0.55
RXRB P28702 3/20 0.55
RXRG P48443 1/20 0.55
PPARA Q07869 2/20 0.49
ALDH1A1 P00352 2/20 0.49
KMT2A Q03164 2/20 0.49
NR4A2 P43354 1/20 0.48
SRD5A2 P31213 1/20 0.47
HSD17B10 Q99714 2/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
ALOX15 P16050 1/20 0.47
MAPK1 P28482 1/20 0.47
BLM P54132 1/20 0.47
CASP7 P55210 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17296531 0.88 CA1 (0.56) NR1H4EPHX2CA1CA2RXRA
SCHEMBL8461643 0.86 CA1 (0.74) NR1H4EPHX2CA1CA2RXRA
SCHEMBL8460674 0.84 NR1H4 (0.58) NR1H4EPHX2CA1CA2RXRA
SCHEMBL29015814 0.81 MEN1 (0.54) CA1CA2ALDH1A1KMT2AHSD17B10
SCHEMBL4418236 0.78 CA1 (0.59) CA1CA2ALDH1A1KMT2AHSD17B10
SCHEMBL8461599 0.77 NR1H4 (0.58) NR1H4EPHX2CA1CA2RXRA
SCHEMBL8461876 0.76 HDAC3 (0.63) NR1H4EPHX2RXRARXRBRXRG
SCHEMBL8460876 0.75 CA1 (0.63) NR1H4EPHX2CA1CA2RXRA
SCHEMBL20236127 0.75 PPARA (0.62) PPARAKMT2ANR4A2SRD5A2MAPT
SCHEMBL5211384 0.75 ALDH1A1 (0.65) NR1H4EPHX2CA1CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999048529-A1 RETINOID-GLITAZONE COMBINATIONS WARNER-LAMBERT COMPANY (US) 1999-09-30 WO disclosed
EP-0808159-A1 USE OR RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) WARNER-LAMBERT COMPANY (US) 1997-11-26 EP disclosed
WO-1996024344-A1 USE OF RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) WARNER-LAMBERT COMPANY (US) 1996-08-15 WO disclosed
US-5489611-A ADMINISTERING A RETINOID COMPOUND WARNER-LAMBERT COMPANY (US) 1996-02-06 US disclosed